Blake Coblentz, a member in Cozen O'Connor's Intellectual Property Department, will participate in a panel discussion titled "Declining to Dance? Lessons Learned from Early BPCIA Cases on Whether the Pathway is Mandatory" at the 6th Annual Summit on Biosimilars. The presentation will include a review of recent biosimilars cases and analysis of the substantive arguments and outcomes in each case.
For more information, click here.